Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy
Clinical trial NCT03404960 · COMPLETED
Trial details
- NCT number
- NCT03404960
- Sponsor
- University of Pennsylvania
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-31
- Primary completion
- 2022-04-05
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.